{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibr4d3cn7ednh7xawbkgqtoffhxz2zhj23v6alsn6ndpa76dx3ruq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mmc4rrpxhen2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/05/20/biotech-investors-mood-former-fda-commissioner-kessler-confidence/?utm_campaign=rss",
  "publishedAt": "2026-05-20T13:55:44.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "For Wall Street, the political risk of investing in drug companies has been demoted in comparison to other concerns",
  "title": "STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more",
  "updatedAt": "2026-05-20T13:55:49.000Z"
}